Development of a novel method for the quantification of tyrosine 39 phosphorylated α- and β-synuclein in human cerebrospinal fluid

BACKGROUND: Parkinson’s disease (PD) is the second most prevalent neurodegenerative disorder. Biomarkers that can help monitor the progression of PD or response to disease-modifying agents will be invaluable in making appropriate therapeutic decisions. Further, biomarkers that could be used to disti...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Clin Proteomics
Main Authors: Na, Chan Hyun, Sathe, Gajanan, Rosenthal, Liana S., Moghekar, Abhay R., Dawson, Valina L., Dawson, Ted M., Pandey, Akhilesh
Formato: Artigo
Idioma:Inglês
Publicado em: BioMed Central 2020
Assuntos:
Research
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC7197159/
https://ncbi.nlm.nih.gov/pubmed/32390785
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s12014-020-09277-8
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados